Search Results 2181-2190 of 15578 for Orange Peel tea

1. General Internal Medicine - Clinical trials

   The primary aim of this study is to determine if the addition of an individual polygenic risk score (PRS) in addition to the Breast Cancer Risk Assessment ...

2. General Internal Medicine - Clinical trials

   The primary aim of this study is to determine if the addition of an individual polygenic risk score (PRS) in addition to the Breast Cancer Risk Assessment ...

3. General Internal Medicine - Clinical trials

   The primary aim of this study is to determine if the addition of an individual polygenic risk score (PRS) in addition to the Breast Cancer Risk Assessment ...

4. Intensity-Modulated Radiation Therapy and Paclitaxel with or without Pazopanib Hydrochloride in Treating Patients with Anaplastic Thyroid Cancer - Mayo Clinic

   Known active invasive malignancy (except for non-melanomatous skin cancer or anaplastic thyroid cancer; the presence of prostate cancer confined to the ...

5. A Study Evaluating Pembrolizumab and Epacadostat in Treating Participants With Recurrent, Persistent, or Progressive Ovarian Clear Cell Carcinoma - Mayo Clinic

   Prior invasive malignancy (except non-melanomatous skin cancer) unless disease free for a minimum of 3 years . Patients who have had prior therapy with MK ...

6. Chemoradiation With or Without Atezolizumab in Treating Patients With Limited Stage Small Cell Lung Cancer - Mayo Clinic

   Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the ...

7. A Study to Evaluate Binimetinib in Combination with Encorafenib in Patients with Pancreatic Malignancies and a Somatic BRAFV600E Mutation - Mayo Clinic

   ... skin, or patients who have had therapy with curative intent for breast or prostate cancer, but remain on adjuvant hormonal therapy. Received anticancer ...

8. A Trial To Investigate Long Term Effectiveness And Safety Of Lonapegsomatropin In Adults With Growth Hormone Deficiency - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

9. Study To Evaluate The Safety, PK, And Dose Response Of Paltusotine In Subjects With Carcinoid Syndrome - Mayo Clinic

   debulking <12 weeks before Screening. 5. Any malignancy except for eligible NET, basal cell or squamous cell skin carcinoma considered clinically cured, or ...

10. Target ALS Biomarker Study - Mayo Clinic

    Subjects medically able to undergo lumbar puncture (LP) as determined by the investigator (i.e.: no bleeding disorder, allergy to local anesthetics, a skin ...